ELECTROMAGNETIC WAVES OPEN NEW HOPE IN THE MANAGEMENT OF DIABETIC POLYNEUROPATHY.

Diabetic Polyneuropathy (DPN) is one of the most common and persistent complications of diabetes. Patients often face burning pain, numbness, tingling, muscle weakness and impaired motor function. These symptoms not only affect mobility but also significantly reduce quality of life.

In this context, a recent study by Vinay Graak and colleagues at Guru Nanak Dev University and Medical College (India) has opened up a promising new direction: Pulsed Electromagnetic Field (PEMF) therapy.

Study Overview

The study was designed as a randomized controlled trial to evaluate the effectiveness of low-frequency PEMF in the management of diabetic polyneuropathy.

Participants:

• 30 patients

• Age: 40–68

• Diagnosed with DPN at stages N1a, N1b, N2a

Treatment groups:

• Group 1: PEMF 600 Hz

• Group 2: PEMF 800 Hz

• Group 3: Standard medical treatment (control)

Treatment regimen:

• 30 minutes per day

• 12 consecutive days

Evaluation indicators:

• Pain level

• Distal nerve latency

• Conduction amplitude

• Nerve conduction velocity

Statistical analysis was performed using a t-test to ensure the reliability of the data.

THE RESULTS SHOW CLEAR IMPROVEMENT IN THE PEMF TREATMENT GROUPS.

Significant Pain Reduction

Both the 600 Hz and 800 Hz groups recorded clear pain reduction compared with the control group. This shows that PEMF can have a positive effect on neuropathic pain mechanisms.

Improved Nerve Conduction

Objective parameters such as:

• Distal latency

• Conduction velocity

all improved with statistical significance (P < 0.05) in the two groups using PEMF.

This is especially important because DPN is not only a matter of pain but also genuine nerve function impairment.

PEMF MAY SERVE AS A PROMISING ADJUNCTIVE THERAPY.

Unlike treatment methods that focus only on symptom control, PEMF is believed to be capable of:

• Improving microcirculation

• Supporting nerve cell regeneration

• Regulating cellular bioelectricity

• Reducing nerve inflammation

A notable point is that this therapy is non-invasive and was well tolerated over the short-term study period.

Clinical Significance and Future Directions

Although the study scale was still small and the follow-up period limited, the initial results show:

• PEMF can reduce pain quickly

• It has a positive effect on nerve function

• It has the potential to slow disease progression

However, larger-scale clinical trials and long-term follow-up are still needed to confirm the long-term effectiveness.

PEMF – A NEW DIRECTION FOR PATIENTS WITH DIABETIC POLYNEUROPATHY.

For those seeking supportive solutions beyond traditional painkillers, PEMF may be an adjunctive option worth considering.

At Arctozen, Arctorus PEMF technology is applied to:

• Support the reduction of neuropathic pain

• Improve circulation

• Optimize cellular function

• Support an enhanced quality of life

Conclusion

ELECTROMAGNETIC WAVES ARE NOT ONLY A NEW TECHNOLOGY BUT ALSO A PROMISING PROSPECT IN THE MANAGEMENT OF DIABETIC NEUROLOGICAL COMPLICATIONS.

Although it does not yet replace standard medical treatment, PEMF is showing potential to become an effective and safe adjunctive therapy.

If you are interested in solutions to support the management of diabetic neurological complications, learn more about PEMF technology at Arctozen for detailed advice tailored to your health condition.